Effectiveness of irinotecan as second-line chemotherapy in small cell lung cancer
Journal Title: Ege Tıp Dergisi - Year 2014, Vol 53, Issue 3
Abstract
Aim: Small cell lung cancer (SCLC) is a progressive and advanced disease. The purpose of this study is to evaluate the response and the hematological side effects of irinotecan chemotherapy in patients with SCLC retrospectively. Materials and Methods: Eighteen patients were included in our study who were between the ages of 30-80 years, had a diagnosis for SCLC, had completed first-line chemotherapy and had taken second-line irinotecan chemotherapy between 01.01.2009 and 01.01.2011. The patients also had archival material which included sufficient information about them and their treatments. All patients had taken at least one course of irinotecan chemotherapy. Data analysis was performed using the SPSS program. Results: Eighteen patients were evaluated. The mean age of the patients was 58.9±7.6 and 89% of the patients were male. After the first-line chemotherapy, treatment response was seen in 78% of the patients and progression was observed in 6% of them. When a radiological evaluation was made after the second-line chemotherapy with irinotecan, a partial response was observed in only 17% of patients, with progression was observed in 61% and stable response was found in 22% of patients. With irinotecan chemotherapy in 28% of patients got improvement of symptoms. The median survival from diagnosis was calculated 91.2±40.2 weeks, the median survival after irinotecan chemotherapy was 31.2±17.2 weeks and time to progression was 15.5±12.0 weeks. Blood transfusion was applicated in 6% of patients and the neutropenia have been observed at least one times in 22% of the patients. Conclusion: It is showed that the second-line irinotecan chemotherapy is partially tolerable although the chemotherapy response rates are low.
Authors and Affiliations
S Özsarı, G Çok
Keywords
Related Articles
- EP ID EP348228
- DOI 10.19161/etd.344073
- Views 92
- Downloads 0
Postoperatif pulmoner komplikasyonları öngörmede yaşam kalitesinin önemi
Amaç: Abdominal cerrahilerde postoperatif pulmoner komplikasyonlar (PPK), morbitide ve mortalitenin önemli bir nedenidir. Ayrıca hastanede yatış süresini uzatan önemli bir faktördür. Preoperatif değerlendirme, komplikasy...
TNF-α inhibitörleri ile tedavi seyrinde gelişen alerjik reaksiyonlar
Kronik romatizmal ve alerjik hastalıkların tedavisinde TNF-α inhibitörleri sıklıkla kullanılır. Şu anda kullanımda olan beş TNF-alfa inhibitörü mevcuttur. Bunlar; infliximab, adalimumab, etanercept, golimumab, certolizum...
Romatizmal hastalıklarda karıştırıcı faktör olarak fibromyalji
Fibromiyalji (FM) yorgunluk, kognitif bozukluk, psikiyatrik semptomlar ve çoklu somatik semptomların eşlik ettiği kronik yaygın kas-iskelet ağrısının başlıca nedenlerinden biridir. FM yaygın olarak romatizmal hastalıklar...
A case of dermatomyositis with a dramatic response to IVIG treatment
Dermatomiyozitis (DM) is an idiopathic inflammatory myopathy and a rare connective tissue disease which is characterized by skin lesions. Diagnosis of DM requires a characteristic rash and other criteria, such as proxima...
Inguinoscrotal bladder hernia detected by SPECT/CT on bone scintigraphy
Inguinal hernia containing bladder is an uncommon and usually asymptomatic condition that occurs at the inguinal canal, scrotal sac or femoral canal. Incidentally detection of inguinal hernia of bladder by bone scintigra...